📊 CSUI Key Takeaways
Is Cannabis Suisse Corp.. (CSUI) a Good Investment?
Cannabis Suisse Corp demonstrates severe financial distress with negative stockholders' equity of -$1.8M, zero revenue, and persistent operating losses. The company is technically insolvent with liabilities ($2.3M) far exceeding assets ($510K), indicating imminent bankruptcy risk without immediate capital restructuring.
Fundamentals are very weak: the company generated no revenue, posted an operating loss, and consumed cash from operations, which points to an unproven and unsustainable business model. The small positive net income does not offset severe balance-sheet stress, including negative equity, very weak liquidity, and liabilities that far exceed assets.
Why Buy Cannabis Suisse Corp.. Stock? CSUI Key Strengths
- Minimal cash burn rate relative to asset base provides short-term operational runway
- Real estate sector classification may provide underlying asset value not reflected in reported metrics
- Low absolute liability amounts suggest manageable debt obligations if operational turnaround occurs
- Reported positive net income in the latest period
- Asset base of roughly $510K provides some underlying balance-sheet resources
- Long-term debt appears to be only part of total liabilities, leaving some flexibility if liabilities can be restructured
CSUI Stock Risks: Cannabis Suisse Corp.. Investment Risks
- Negative stockholders' equity of -$1.8M indicates technical insolvency and substantial shareholder dilution risk
- Zero revenue with -$159.5K operating losses demonstrates complete lack of business operations or commercial viability
- Critically low liquidity with 0.19x current ratio and only $2.6K cash against $2.3M liabilities creates immediate solvency crisis
- Long-term debt of $610.7K against zero revenue makes debt service mathematically impossible without external capital injection
- Negative operating cash flow of -$32.2K with zero revenue indicates business cannot sustain itself operationally
- Zero revenue and declining top line indicate no operating traction
- Negative stockholders' equity and a 0.19x current ratio signal serious financial distress
- Negative operating cash flow and negative interest coverage suggest weak ability to fund operations and service obligations
Key Metrics to Watch
- Stockholders' equity trajectory and any debt restructuring announcements
- Revenue generation or business combination announcements indicating operational restart
- Cash position changes and any capital raises or financing activities through Form 4/8-K filings
- Revenue generation and operating cash flow
- Current ratio and stockholders' equity improvement
Cannabis Suisse Corp.. (CSUI) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CSUI Profit Margin, ROE & Profitability Analysis
CSUI vs Real Estate Sector: How Cannabis Suisse Corp.. Compares
How Cannabis Suisse Corp.. compares to Real Estate sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Cannabis Suisse Corp.. Stock Overvalued? CSUI Valuation Analysis 2026
Based on fundamental analysis, Cannabis Suisse Corp.. has mixed fundamental signals relative to the Real Estate sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Cannabis Suisse Corp.. Balance Sheet: CSUI Debt, Cash & Liquidity
CSUI Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Cannabis Suisse Corp..'s revenue has declined by 88% over the 5-year period, indicating business contraction. The most recent EPS of $-0.03 indicates the company is currently unprofitable.
CSUI Revenue Growth, EPS Growth & YoY Performance
CSUI Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | N/A | $5.1K | $0.00 |
| Q1 2026 | N/A | $13.9K | $0.00 |
| Q3 2025 | $7.5K | $29.5K | $0.00 |
| Q2 2025 | $7.5K | $5.1K | $0.00 |
| Q1 2025 | $7.5K | -$64.8K | N/A |
| Q3 2024 | $2.5K | -$68.0K | N/A |
| Q2 2024 | N/A | -$30.1K | N/A |
| Q1 2024 | N/A | -$64.8K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Cannabis Suisse Corp.. Dividends, Buybacks & Capital Allocation
CSUI SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Cannabis Suisse Corp.. (CIK: 0001680132)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CSUI
What is the AI rating for CSUI?
Cannabis Suisse Corp.. (CSUI) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 94% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CSUI's key strengths?
Claude: Minimal cash burn rate relative to asset base provides short-term operational runway. Real estate sector classification may provide underlying asset value not reflected in reported metrics. ChatGPT: Reported positive net income in the latest period. Asset base of roughly $510K provides some underlying balance-sheet resources.
What are the risks of investing in CSUI?
Claude: Negative stockholders' equity of -$1.8M indicates technical insolvency and substantial shareholder dilution risk. Zero revenue with -$159.5K operating losses demonstrates complete lack of business operations or commercial viability. ChatGPT: Zero revenue and declining top line indicate no operating traction. Negative stockholders' equity and a 0.19x current ratio signal serious financial distress.
What is CSUI's revenue and growth?
Cannabis Suisse Corp.. reported revenue of $0.0.
Does CSUI pay dividends?
Cannabis Suisse Corp.. does not currently pay dividends.
Where can I find CSUI SEC filings?
Official SEC filings for Cannabis Suisse Corp.. (CIK: 0001680132) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CSUI's EPS?
Cannabis Suisse Corp.. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is CSUI a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Cannabis Suisse Corp.. has a STRONG SELL rating with 94% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is CSUI stock overvalued or undervalued?
Valuation metrics for CSUI: ROE of N/A (sector avg: 8%), net margin of N/A (sector avg: 20%). Compare these metrics with sector averages to assess valuation.
Should I buy CSUI stock in 2026?
Our dual AI analysis gives Cannabis Suisse Corp.. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CSUI's free cash flow?
Cannabis Suisse Corp..'s operating cash flow is $-32.2K, with capital expenditures of N/A.
How does CSUI compare to other Real Estate stocks?
Vs Real Estate sector averages: Net margin N/A (avg: 20%), ROE N/A (avg: 8%), current ratio 0.19 (avg: 1.5).